Cepheid (United States)

15.1k citations
334 papers ·

Impact in

    • Tuberculosis Research and Epidemiology
    • Antimicrobial Resistance in Staphylococcus
    • SARS-CoV-2 detection and testing
    • Clostridium difficile and Clostridium perfringens research
    • Bacterial Identification and Susceptibility Testing

Papers in

    • Tuberculosis Research and Epidemiology 29
    • Antimicrobial Resistance in Staphylococcus 27
    • SARS-CoV-2 detection and testing 20
    • Antibiotic Resistance in Bacteria 36

Cepheid (United States)

319 papers receiving 15.1k citations

Peers

Cepheid (United States)
Comparison fields: 5 of 182
  • Infectious Diseases 6.4k
  • Clinical Biochemistry 720
  • Molecular Medicine 821
  • Applied Microbiology and Biotechnology 236
  • Microbiology 322
Replace Theravance Biopharma (United States) with:
Theravance Biopharma (United States) United States
BD Biosciences (United States) United States
F. Widjaja Inflammatory Bowel Disease Institute United States
Oregon Health Authority United States
California Institute for Biomedical Research United States
Beckman Coulter (United States) United States
Alta Bates Summit Medical Center United States
Corixa Corporation United States
John Muir Health United States
Torrance Memorial Medical Center United States
Cepheid (United States) relative to Theravance Biopharma (United States) United States Theravance Biopharma (United States)'s profile →
Citations per field
00.5×5×10×12.6×
Theravance Biopharma (United States) · 1×
Citations per year

Countries citing scholars working at Cepheid (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Cepheid (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Cepheid (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cepheid (United States) more than expected).

Fields of papers published by authors at Cepheid (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Cepheid (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Cepheid (United States) at the time of their publication.

About Cepheid (United States)

In recent decades, authors affiliated with Cepheid (United States) have published 334 papers, which have received a total of 15.1k indexed citations . Scholars at this organization have produced 102 papers in Infectious Diseases, 36 papers in Molecular Medicine, 26 papers in Clinical Biochemistry, 13 papers in Microbiology and 4 papers in Applied Microbiology and Biotechnology on the topics of Antibiotic Resistance in Bacteria (36 papers), Tuberculosis Research and Epidemiology (29 papers), Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (26 papers), Microfluidic and Capillary Electrophoresis Applications (20 papers), SARS-CoV-2 detection and testing (20 papers), Biosensors and Analytical Detection (20 papers) and Clinical Laboratory Practices and Quality Control (15 papers). Their work is cited by papers focused on Infectious Diseases (6.4k citations), Clinical Biochemistry (720 citations), Molecular Medicine (821 citations), Applied Microbiology and Biotechnology (236 citations) and Microbiology (322 citations). Authors at Cepheid (United States) collaborate with scholars in United States, China and United Kingdom and have published in prestigious journals including Journal of Clinical Microbiology, Clinical Infectious Diseases, PLoS ONE, Journal of Molecular Diagnostics and Antimicrobial Agents and Chemotherapy. Some of Cepheid (United States)'s most productive authors include Fred C. Tenover, Michael J. Loeffelholz, David H. Persing, Yi‐Wei Tang, Richard Vernon Goering, K. Petersen, G.T.A. Kovacs, David Alland, Nadim I. Maluf and Robert Blakemore.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact